Workflow
万凯新材(301216) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 reached ¥5,746,053,814.88, representing a 165.20% increase year-over-year[6] - Net profit attributable to shareholders was ¥341,547,736.07, up 291.32% compared to the same period last year[6] - The basic earnings per share for Q3 2022 was ¥0.99, representing a 191.18% increase year-over-year[6] - Total operating revenue for the current period reached ¥14,772,399,482.59, a significant increase from ¥6,587,849,814.03 in the previous period, representing a growth of approximately 124%[28] - Net profit for the current period was ¥883,874,263.97, compared to ¥275,480,253.29 in the previous period, marking an increase of about 220%[28] - The company’s basic and diluted earnings per share increased to ¥2.81 from ¥1.07, reflecting a growth of approximately 162%[28] Cash Flow and Liquidity - The net cash flow from operating activities was ¥398,575,640.60, a significant increase of 788.91% year-over-year[6] - Net cash flow from operating activities reached $330.78 million, a 344.66% increase, driven by the commencement of production at Chongqing Wankai Phase II and increased sales[14] - Cash flow from operating activities generated a net amount of ¥330,780,946.01, a turnaround from a negative cash flow of ¥135,201,983.71 in the previous period[31] - Cash and cash equivalents stood at CNY 3,685,187,249.31, a substantial increase from CNY 610,153,399.84[21] - Cash and cash equivalents at the end of the period totaled ¥2,527,361,809.91, up from ¥628,444,104.62, indicating a substantial increase[31] Assets and Liabilities - Total assets as of the end of Q3 2022 amounted to ¥11,410,166,681.61, reflecting a 63.07% increase from the end of the previous year[6] - Current assets reached CNY 8,265,443,362.55, compared to CNY 4,018,099,710.09 in the previous year, indicating a growth of approximately 105.5%[24] - The company's total liabilities reached CNY 5,889,796,969.25, compared to CNY 5,206,916,709.26, marking an increase of about 13.1%[24] - The equity attributable to shareholders increased to CNY 5,520,369,712.36 from CNY 1,790,246,690.31, showing a growth of approximately 208.5%[24] Investment and Expenses - R&D expenses increased to $34.34 million, up 136.48% year-over-year, primarily due to increased investment in research and development[14] - The company reported a significant increase in investment income, reaching ¥26,856,214.87 compared to ¥7,952,613.45 in the previous period, representing an increase of approximately 237%[28] - Financial expenses decreased to $36.69 million, down 38.64% year-over-year, mainly due to increased interest income and foreign exchange gains[14] - The company experienced a substantial increase in non-operating expenses, which rose to $2.01 million, up 1187.00% year-over-year, primarily due to increased donations during the pandemic[14] Market Strategy and Future Plans - The company plans to continue expanding its market presence and investing in new product development to sustain growth[11] - The company has plans for market expansion and new product development, although specific figures were not disclosed in the conference call[20]